Fluidigm (NASDAQ:FLDM) Latest News, Stock Price and Trading Information

CORRECTING and REPLACING - Fluidigm Announces Second Quarter 2019 Financial Results

Globe Newswire 2-Aug 12:41 AM

Fluidigm Announces Second Quarter 2019 Financial Results

Globe Newswire 1-Aug 4:05 PM

Jonathan Day Named VP, Commercial Operations, Americas

Globe Newswire 1-Aug 4:01 PM

Fluidigm to Automate RNA Sequencing Library Preparation Using Microfluidics Technology

Globe Newswire 1-Aug 8:31 AM

Fluidigm Announces 3rd Annual Imaging Mass Cytometry User Group Meeting

Globe Newswire 30-Jul 8:30 AM

Bill W. Colston Named to Fluidigm Board of Directors

Globe Newswire 25-Jul 8:30 AM

Fluidigm Announces Conference Call and Webcast of Second Quarter 2019 Financial Results

Globe Newswire 3-Jul 1:05 PM

Fluidigm Highlights New Advancements in Deep Cellular Profiling from Circulation to Tissue at CYTO 2019

Globe Newswire 20-Jun 8:31 AM

Fluidigm Introduces Three Imaging Mass Cytometry Panel Kits and Advanced CyTOF Software to Accelerate Immuno-Oncology Research

Globe Newswire 19-Jun 8:31 AM

Fluidigm Scales Highly Multiplexed Cell Analysis with Introduction of Seven New Metal Markers

Globe Newswire 17-Jun 8:31 AM

Oncology Researcher Andrew Quong Joins Fluidigm as Chief Science Officer

Globe Newswire 4-Jun 8:30 AM

Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Globe Newswire 31-May 5:37 PM